She told STAT she leads a team of around 100 distributors and isnt opposed to science, but questioned the motivations of health officials who established vaccine mandates and the companies that manufactured them a common anti-vaccine talking point
The multiple cardiometabolic benefits include improving glycemic control, lipid profiles, blood pressure, inflammation, and hepatic steatosis
And importantly, these brands have also helped us build a credible relationship with healthcare professionals, key partners in solving these challenges for GLP-1 patients. Mondelz International: The whole topic has been overblown At snacks and confectionery giant Mondelz International, chairman and CEO Dirk Van de Put told analysts during his firms latest earnings call that the whole topic has been overblown
In addition, although earlier GLP-1 medications have been used safely for decades in people with diabetes, the long-term effects of lifelong use of newer, more potent agonists remain unknown
Patients try to solve these three problems in multiple ways
However, even with these promising developments, the largely unregulated exploitative marketplace for selling GLP-1 products persists and now involves marketing personalized compounded GLP-1 weight-loss drugs, which can cause harm due to unknown formulations, dosing errors, and severe side effects
